Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0GEOJG
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
NBT-508
|
|||||
| Synonyms |
NBT 508; NBT508
Click to Show/Hide
|
|||||
| Organization |
NewBio Therapeutics; TOT BIOPHARM International Co. Ltd.; Xingang Biomedical Technology (Shanghai) Co., Ltd.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 1 Indication(s)
Non Hodgkin lymphoma [ICD11:2B33]
Phase 1
|
|||||
| Drug-to-Antibody Ratio |
2
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
B-cell antigen receptor complex-associated protein beta chain (CD79B)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.